http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113278041-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 |
filingDate | 2021-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113278041-B |
titleOfInvention | Nucleoside phosphate and its synthesis method and application in preparing medicine for anti hepatitis virus |
abstract | The invention belongs to the technical field of medicinal chemistry, and particularly relates to nucleoside phosphate and a synthesis method thereof, and pharmaceutical application of the nucleoside phosphate in resisting hepatitis viruses. The nucleoside phosphate is 2-sulfo-N-hydroxyl cytosine ribonucleoside phosphate, and the synthetic method has simple steps and high product yield. Experiments prove that the compound 2-sulfo-N-hydroxycytosine ribonucleoside phosphate has good inhibition effect on HBV DNA secreted by HepG2.2.15 cells, has anti-hepatitis virus activity and provides a good choice for treating viral hepatitis. |
priorityDate | 2021-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.